Wednesday, November 03, 2021 10:32:21 PM
New @NEJM
— Eric Topol (@EricTopol) November 3, 2021
The impact of waning immunity in the Moderna COVE vaccine trial over time and with 97% Delta variant https://t.co/q2vhymCvEr pic.twitter.com/EpPp49PEMx
New @NEJM
The impact of waning immunity in the Moderna COVE vaccine trial over time and with 97% Delta variant https://www.nejm.org/doi/full/10.1056/NEJMc2115597
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
